PennantPark Investment Corporation
NYSE:PNNTAsset Management
+$0.01 today
- Market cap
- $188.71M
- Beta
- 0.59
- P/E (TTM)
- 16.7
- EPS (TTM)
- $0.22
- Dividend yield
- 24.41%
Volume 0.81M
Average 0.79M
PNNT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
PennantPark Investment CorporationNYSE: PNNT
Research & Development · Q2 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 0 | — |
| FY2024 | 2024-09-30 | 0 | — |
| FY2023 | 2023-09-30 | 0 | — |
| FY2022 | 2022-09-30 | 0 | — |
| FY2021 | 2021-09-30 | 0 | — |
Research & Development vs competitors
How PNNT compares with its peers on the latest reported figures
- PNNT's LTM Mar 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for PNNT, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| FY2025 | $0 | — | — | 0.0% | |
| LTM Jun 2025 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Dec 2025 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Feb 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PNNT) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for PNNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 193.82M | 23.8M | 19.24M | 103.7M | 83.08M |
| Cost of Revenue | 22.51M | 28.76M | 39.41M | 45.19M | 41.32M |
| Gross Profit | 171.31M | (4.96M) | (20.17M) | 58.51M | 41.76M |
| Gross Margin | 88.4% | -20.8% | -104.8% | 56.4% | 50.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 4.1M | 3.89M | 5.68M | 6.56M | 1.49M |
| Operating Expenses | 4.1M | 11.9M | 5.97M | 6.56M | 6.47M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 167.22M | (16.86M) | (26.14M) | 51.95M | 35.29M |
| EBITDA Margin | 86.3% | -70.8% | -135.8% | 50.1% | 42.5% |
| Operating Income | 167.22M | (16.86M) | (26.14M) | 51.95M | 35.29M |
| Operating Margin | 86.3% | -70.8% | -135.8% | 50.1% | 42.5% |
| Interest Income | 71.09M | 87.43M | 113.38M | 115.84M | 98.17M |
| Interest Expense | 22.51M | 28.76M | 39.41M | 45.19M | 41.32M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 167.22M | (16.86M) | (26.14M) | 51.95M | 35.29M |
| Pre-Tax Margin | 86.3% | -70.8% | -135.8% | 50.1% | 42.5% |
| Income Tax Expense | 600K | 7.88M | 7.67M | 3.1M | 2.56M |
| Net Income | 166.62M | (24.74M) | (33.81M) | 48.85M | 32.73M |
| Net Margin | 86.0% | -103.9% | -175.7% | 47.1% | 39.4% |
| EPS (Basic) | 2.49 | (0.38) | (0.52) | 0.75 | 0.50 |
| EPS (Diluted) | 2.49 | (0.38) | (0.52) | 0.75 | 0.50 |
| Weighted Avg Shares | 67.05M | 65.22M | 65.01M | 65.25M | 65.3M |
| Weighted Avg Shares (Diluted) | 67.05M | 65.22M | 65.22M | 65.25M | 65.3M |
PennantPark Investment Corporation
NYSE:PNNT
Intrinsic Alpha fair value
Locked
Current Price
$2.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.